Prognostic and predictive value of TP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial - Concepedia

Concepedia

Publication | Open Access

Prognostic and predictive value of TP53mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial

DOI Full Paper Access

57

Citations

35

References

2012

Year

Lynnette Fernandez‐Cuesta, Catherine Oakman, Priscila Falagan-Lotsch, Ke-seay Smoth, Emmanuel Quinaux, Marc Buyse, Mirko Dolci, Evandro de Azambuja, Pierre Hainaut, Patrizia Dell’Orto,

Breast Cancer Research

References

	Year	Citations

Page 1